BE824861A - Compositions anti-inflammatoires et leur utilisation - Google Patents

Compositions anti-inflammatoires et leur utilisation

Info

Publication number
BE824861A
BE824861A BE152776A BE152776A BE824861A BE 824861 A BE824861 A BE 824861A BE 152776 A BE152776 A BE 152776A BE 152776 A BE152776 A BE 152776A BE 824861 A BE824861 A BE 824861A
Authority
BE
Belgium
Prior art keywords
inflammatory compositions
inflammatory
compositions
Prior art date
Application number
BE152776A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE824861A publication Critical patent/BE824861A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE152776A 1974-02-22 1975-01-28 Compositions anti-inflammatoires et leur utilisation BE824861A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US446197A US3928588A (en) 1974-02-22 1974-02-22 Method of reducing the undesirable gastrointestinal effects of prostaglandin synthetase inhibitors

Publications (1)

Publication Number Publication Date
BE824861A true BE824861A (fr) 1975-07-28

Family

ID=23771676

Family Applications (1)

Application Number Title Priority Date Filing Date
BE152776A BE824861A (fr) 1974-02-22 1975-01-28 Compositions anti-inflammatoires et leur utilisation

Country Status (4)

Country Link
US (1) US3928588A (fr)
BE (1) BE824861A (fr)
GB (1) GB1463954A (fr)
ZA (1) ZA748217B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081553A (en) * 1976-02-17 1978-03-28 The Upjohn Company Cytoprotective prostaglandins for use in human intestinal diseases
GB1533928A (en) * 1976-04-14 1978-11-29 Ici Ltd Oestrus regulation
AU2064783A (en) * 1982-11-05 1984-05-10 Procter & Gamble Company, The Cytoprotective prostoglandins and histamine-2-receptor blocking actents
GB2135881A (en) * 1983-03-02 1984-09-12 Erba Farmitalia Method and pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs
US5840280A (en) * 1996-05-30 1998-11-24 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Silicone copolyol formulated hairspray compositions
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
WO2000051980A1 (fr) 1999-03-05 2000-09-08 The Procter & Gamble Company Analogues de prostaglandines c16 fp selectives insaturees
US6183779B1 (en) 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20090012165A1 (en) * 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781429A (en) * 1972-09-29 1973-12-25 American Cyanamid Co Method of inhibiting ulcerogenesis induced by non-steroidal anti-inflammatory agents

Also Published As

Publication number Publication date
US3928588A (en) 1975-12-23
ZA748217B (en) 1976-01-28
AU7700974A (en) 1976-07-01
GB1463954A (en) 1977-02-09

Similar Documents

Publication Publication Date Title
BE837087A (fr) Polyarylethersulfones sulfonees et leur application
BE824861A (fr) Compositions anti-inflammatoires et leur utilisation
BE852283A (fr) Compositions carcinostatiques et leur utilisation
FR2325635A1 (fr) N-alkyldiphenylamines et leur utilisation comme rodonticides
BE833586A (fr) Aminobenzazocines et leur preparation
BE832860A (fr) Benzo-isoquinoleine-diones et leur preparation
BE835175A (fr) Compositions sterilisantes et leur utilisation
BE833369A (fr) Nouvelles benzodiazepines et leur preparation
BE832921A (fr) Nouvelles rifamycines et leur preparation
BR7503611A (pt) Composicoes organosilicicas e respectiva utilizacao
IT1039489B (it) Composizioni azidosilaniche
IT1039490B (it) Composizioni azidosilaniche
AR204751A1 (es) As y horticolas
BE825982A (fr) Triazoloquinazolines et leur preparation
SE7512053L (sv) Nitroparaffinhaltiga explosiva kompositioner
BE830238A (fr) Compositions antiparkinsoniennes et leur utilisation
BE825039A (fr) Leuco-colorants d'indolyl-methylene, leur preparation et leur utilisation
BE831041A (fr) Nouvelles compositions galeniques et leur preparation
BE824858A (fr) Compositions anti-inflammatoires et leur utilisation
BE824859A (fr) Compositions anti-inflammatoires et leur utilisation
FR2280636A1 (fr) Sulfonamidothiophenes fongicides et leur application
BE824860A (fr) Compositions anti-inflammatoires et leur utilisation
BE830239A (fr) Compositions de steroides stabilisees et leur preparation
BE826925A (fr) Nouvelles pyrrolodiazepines et leur preparation
FR2276810A1 (fr) Compositions cosmetiques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE UPJOHN CY

Effective date: 19850128